User:Mr. Ibrahem/Avelumab

Avelumab, sold under the brand name Bavencio, is a medication used to treat Merkel cell carcinoma, urothelial carcinoma, and renal cell cancer. It is used as long as it is working and the side effects are not too severe. It is give by injection into a vein.

Common side effects include tiredness, nausea, diarrhea, infusion reaction, and weight loss. Other side effects may include immune-mediated disorders such as pneumonitis and colitis, as well as low red blood cells and shortness of breath. Use in pregnancy may harm the baby. It is a monoclonal antibody that attaches to the protein programmed death-ligand 1 (PD-L1), allowing the immune system to kill cancer cells.

Avelumab was approved for medical use in the United States and Europe in 2017. In the United Kingdom a 4 weeks costs the NHS about £6,100 as of 2021. In the United States this amount costs about 14,300 USD.